dr. brufsky advises doctors on bevacizumab for breast cancer
Published 12 years ago • 315 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
1:06
dr. brufsky on challenges in breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:49
dr. brufsky discusses pertuzumab in her2 breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:36
dr. rugo on the efficacy of bevacizumab in breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
0:39
dr. brufsky discusses future research into bisphosphonates
-
2:20
dr. brufsky on choosing when to do a multiparameter genomic assay
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
1:00
dr. slamon on the use of trastuzumab and bevacizumab biosimilars in breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:31
dr. brufsky discusses the tnacity trial
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc